Diabetic retinopathy can lead to peripheral or nighttime vision loss, visual disturbances, and, if left untreated, blindness.

Initiating empagliflozin vs a DPP-4 inhibitor may slow the progression of diabetic retinopathy in patients with type 2 ...

"To our knowledge, this is the first study to evaluate diabetic retinopathy progression using data generated from clinical ...

The anterior chambers were deep and clear in both eyes. Examination revealed cortical cataract and pre-proliferative diabetic retinopathy in the both eyes. Uneventful phacoemulsification cataract ...

Diabetic retinopathy (DR) affects about 26 percent of people with diabetes. While many patients have an early form of DR, the condition can progress, posing the threat of irreversible vision loss.

They included adults with type 2 diabetes initiating study drugs without prior diagnosis or treatment for proliferative diabetic retinopathy or other advanced retinal diseases. For the incident ...